BioCentury
ARTICLE | Company News

Merck & Co. Inc, Schering-Plough metabolic news

April 7, 2008 7:00 AM UTC

Sen. Chuck Grassley (R-Iowa) sent letters to Merck and Schering-Plough requesting details of payments made to key opinion leaders for Vytorin ezetimibe/simvastatin since November 2007 and the compani...